Replies to post #6190 on Ekso Bionics Holdings Inc (EKSO)

[Majestic_Delight]

Rewalk R/S Timeline:

10/26/18 received listing compliance notice from Nasdaq claiming that the company was in violation of Nasdaq rule 5550(a)(2) [share price above $1/sh standard] and Nasdaq rule 5550(b) [$35M value of market securities or $2.5M shareholder equity and $500K net income standard].

03/27/19 Shareholders vote for R/S at annual shareholder meeting.

03/29/19 1:25 R/S announced.

04/01/19 1:25 R/S enacted.

04/12/19 completion of 10 consecutive days with share price above $1/sh.

04/15/19 regain listing compliance with Nasdaq rule 5550(a)(2).